EX-23.1 3 tm259851d1_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

   
  KPMG LLP
Suite 4000
1735 Market Street
Philadelphia, PA 19103-7501      

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the use of our report dated March 21, 2025, with respect to the consolidated financial statements of TELA Bio, Inc. and subsidiaries, incorporated herein by reference.

 

  /s/ KPMG LLP  

 

Philadelphia, Pennsylvania
March 21, 2025